Keywords: biogen, idec, seeks, pd, treatment, ngr1, biotechnology

Biogen Idec seeks PD treatment in NgR1

Article | 05 December 2005

Print This

US biotechnology firm Biogen Idec says that it has discovered a new receptor that might be involved in the progression ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in